Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSP90AA2P is a predicted heat shock protein 90 alpha family class A member 2 pseudogene. It shares sequence similarity with functional HSP90 proteins, which are highly conserved molecular chaperones involved in the folding, maturation, and degradation of cellular proteins. HSP90AA2P itself lacks protein-coding function and is not established as a direct participant in protein folding, signaling, or disease mechanisms. The functional variants of HSP90 are well-studied for their critical roles in cellular stress responses and have clinical significance in cancer therapy as therapeutic targets, but HSP90AA2P is not among the protein-coding, druggable HSP90 family members. If your interest is in pharmacological targets within the HSP90 family, you should look at protein-coding genes such as "Heat shock protein 90 alpha" (HSP90AA1) or "Heat shock protein 90 beta" (HSP90AB1).
null for the pseudogene. For functional HSP90 proteins, mechanism of action typically involves inhibition of ATP binding to disrupt chaperone activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein 90 alpha family class A member 2 pseudogene (HSP90AA2P).